Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy

Peykan Turkcuoglu, Peter Y. Chang, Zubir S. Rentiya, Roomasa Channa, Mohamed Ibrahim, Elham Hatef, Raafay Sophie, Ama Sadaka, Jianmin Wang, Yasir J. Sepah, Diana V. Do, C. Stephen Foster, Quan Dong Nguyen

Research output: Contribution to journalArticle

Abstract

Purpose: To compare the frequencies of attacks before and after immunomodulatory therapy (IMT) with mycophenolate mofetil (MMF) in recurrent punctate inner choroidopathy (PIC) and to report fundus autofluorescence (FAF) findings. Methods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38%) patients experienced 6 recurrent episodes. The attack frequencies were 1.09±0.75 before and 0.23±0.32 during treatment (p=.036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.

Original languageEnglish (US)
Pages (from-to)286-292
Number of pages7
JournalOcular Immunology and Inflammation
Volume19
Issue number4
DOIs
StatePublished - Aug 2011
Externally publishedYes

Fingerprint

Mycophenolic Acid
Immunomodulation
Therapeutics
Recurrence

Keywords

  • fundus autofluorescence
  • immunomodulatory therapy
  • mycophenolate mofetil
  • punctate inner choroidopathy
  • recurrence

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. / Turkcuoglu, Peykan; Chang, Peter Y.; Rentiya, Zubir S.; Channa, Roomasa; Ibrahim, Mohamed; Hatef, Elham; Sophie, Raafay; Sadaka, Ama; Wang, Jianmin; Sepah, Yasir J.; Do, Diana V.; Foster, C. Stephen; Nguyen, Quan Dong.

In: Ocular Immunology and Inflammation, Vol. 19, No. 4, 08.2011, p. 286-292.

Research output: Contribution to journalArticle

Turkcuoglu, P, Chang, PY, Rentiya, ZS, Channa, R, Ibrahim, M, Hatef, E, Sophie, R, Sadaka, A, Wang, J, Sepah, YJ, Do, DV, Foster, CS & Nguyen, QD 2011, 'Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy', Ocular Immunology and Inflammation, vol. 19, no. 4, pp. 286-292. https://doi.org/10.3109/09273948.2011.580072
Turkcuoglu, Peykan ; Chang, Peter Y. ; Rentiya, Zubir S. ; Channa, Roomasa ; Ibrahim, Mohamed ; Hatef, Elham ; Sophie, Raafay ; Sadaka, Ama ; Wang, Jianmin ; Sepah, Yasir J. ; Do, Diana V. ; Foster, C. Stephen ; Nguyen, Quan Dong. / Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy. In: Ocular Immunology and Inflammation. 2011 ; Vol. 19, No. 4. pp. 286-292.
@article{fa113aaab92349eebc9ae6d4cf102a80,
title = "Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy",
abstract = "Purpose: To compare the frequencies of attacks before and after immunomodulatory therapy (IMT) with mycophenolate mofetil (MMF) in recurrent punctate inner choroidopathy (PIC) and to report fundus autofluorescence (FAF) findings. Methods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38{\%}) patients experienced 6 recurrent episodes. The attack frequencies were 1.09±0.75 before and 0.23±0.32 during treatment (p=.036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.",
keywords = "fundus autofluorescence, immunomodulatory therapy, mycophenolate mofetil, punctate inner choroidopathy, recurrence",
author = "Peykan Turkcuoglu and Chang, {Peter Y.} and Rentiya, {Zubir S.} and Roomasa Channa and Mohamed Ibrahim and Elham Hatef and Raafay Sophie and Ama Sadaka and Jianmin Wang and Sepah, {Yasir J.} and Do, {Diana V.} and Foster, {C. Stephen} and Nguyen, {Quan Dong}",
year = "2011",
month = "8",
doi = "10.3109/09273948.2011.580072",
language = "English (US)",
volume = "19",
pages = "286--292",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Mycophenolate mofetil and fundus autofluorescence in the management of recurrent punctate inner choroidopathy

AU - Turkcuoglu, Peykan

AU - Chang, Peter Y.

AU - Rentiya, Zubir S.

AU - Channa, Roomasa

AU - Ibrahim, Mohamed

AU - Hatef, Elham

AU - Sophie, Raafay

AU - Sadaka, Ama

AU - Wang, Jianmin

AU - Sepah, Yasir J.

AU - Do, Diana V.

AU - Foster, C. Stephen

AU - Nguyen, Quan Dong

PY - 2011/8

Y1 - 2011/8

N2 - Purpose: To compare the frequencies of attacks before and after immunomodulatory therapy (IMT) with mycophenolate mofetil (MMF) in recurrent punctate inner choroidopathy (PIC) and to report fundus autofluorescence (FAF) findings. Methods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38%) patients experienced 6 recurrent episodes. The attack frequencies were 1.09±0.75 before and 0.23±0.32 during treatment (p=.036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.

AB - Purpose: To compare the frequencies of attacks before and after immunomodulatory therapy (IMT) with mycophenolate mofetil (MMF) in recurrent punctate inner choroidopathy (PIC) and to report fundus autofluorescence (FAF) findings. Methods: Eight patients who had at least two recurrent episodes of increased activity before MMF and 12 months of documented clinical course before and after MMF were included. The frequencies of attacks before and after MMF were compared. FAF images evaluated. Results: Before MMF, the 8 patients experienced 19 attacks of recurrent disease activity; during MMF therapy, 3 (38%) patients experienced 6 recurrent episodes. The attack frequencies were 1.09±0.75 before and 0.23±0.32 during treatment (p=.036). Among the 6 patients who had FAF, surrounding hyperautofluorescent halo was detected in 4 and recurrence occurred in 2 who did not show any changes on the intensity during treatment. Conclusion: In the index study, the employment of MMF has decreased frequency of attacks in recurrent PIC. FAF may be employed to monitor and predict the response to treatment.

KW - fundus autofluorescence

KW - immunomodulatory therapy

KW - mycophenolate mofetil

KW - punctate inner choroidopathy

KW - recurrence

UR - http://www.scopus.com/inward/record.url?scp=79960672974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960672974&partnerID=8YFLogxK

U2 - 10.3109/09273948.2011.580072

DO - 10.3109/09273948.2011.580072

M3 - Article

VL - 19

SP - 286

EP - 292

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 4

ER -